- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
GW Pharmaceuticals PLC
+ Add to WatchlistGWPRF:US
0.7400 USD 0.0200 2.78%As of 20:10:00 ET on 05/24/2013.
Company Profile for GW Pharmaceuticals PLC (GWPRF)
GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.
Contact Information
GW Pharmaceuticals PLC
Porton Down Science Park
Salisbury
Wiltshire, SP4 0JQ
United Kingdom
Key Executives for GW Pharmaceuticals PLC (GWPRF)
| Geoffrey William GuyChairman/Founder | Justin David GoverChief Executive Officer |
| Adam David GeorgeCFO/Secretary | Christopher John Tovey "Chris"Chief Operating Officer |
| Alice MeadVP:US Professional Relations | Stephen D SchultzVP:Investor Relations |
| Stephen WrightDirector:Research & Dev | Marilyn EmeryDirector:Quality |
| Peter GibsonDirector:Technical | Manuel LouredaDirector:Manufacturing Ops |
| Roger PertweeDirector:Pharmacology | David PotterDirector:Botanical Research |
| Richard PottsDirector:Clinical Operations | Colin StottDirector:Research & Dev Ops |
| Alison ThompsonDirector:Regulatory Affairs | Paul PritchardDirector:Supply Chain |
| Philip RobsonDirector:Cannabinoid | Renuka SoleyManager:Sativex Global Bus |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page